Third Rock Ventures
Third Rock Ventures builds biotech companies from scratch around a scientific idea, then funds and staffs them. Several of the best-known precision oncology companies of the last fifteen years started in its offices.
Overview
Third Rock Ventures is a Boston venture firm whose model is company creation: partners incubate a concept, assemble founding scientists and an interim management team, and fund the company through its first years before it raises from others or lists. Oncology has been a central theme since the firm's founding in 2007, with companies built around genomic profiling, kinase inhibitors, cancer metabolism, synthetic lethality and targeted immunotherapies, and a habit of pairing a therapeutic platform with a diagnostic rationale. Its portfolio pages list current and former companies; portfolio links in OnCo are derived from the startup records that name Third Rock as an investor.
Portfolio in OnCo (1)
Filter the startups table| Company | Stage | Type | Cancers | Latest round |
|---|---|---|---|---|
| Asher Biotherapeutics South San Francisco, CA, US · YC S19 | Growth stage | biotech | Renal cell carcinomaMelanoma | none on record |